Open Access

Role of chemokines in early pregnancy loss

  • Authors:
    • Sefi̇k Gokce
    • Di̇lsad Herki̇loglu
    • Ozge Cevi̇k
    • Volkan Turan
  • View Affiliations

  • Published online on: April 14, 2022     https://doi.org/10.3892/etm.2022.11324
  • Article Number: 397
  • Copyright: © Gokce et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to compare decidual protein levels and gene expression levels of chemokines between patients with early pregnancy loss and those with voluntary abortion. A total of 15 patients between 6 and 10 gestational weeks, who presented with negative fetal heartbeat to the obstetrics and gynecology outpatient clinics of Gaziosmanpasa Hospital (Yeni Yuzyil University, Istanbul, Turkey) and who had no additional systemic disease and 13 patients between 6 and 10 gestational weeks, who presented with positive fetal heartbeat for voluntary abortion were included in the present study. CX3CL1, CCL17, CXCR4, chemokine ligand 12 (CXCL12) and intercellular adhesion molecule (ICAM)5 protein expression levels were determined by ELISA and gene expression levels by reverse transcription‑quantitative PCR in fresh materials recovered after therapeutic curettage. CX3CL1, CCL17, CXCR4, CXCL12 protein levels were significantly higher and ICAM protein level was significantly lower in pregrant women with missed abortion compared with those with voluntary abortion. While the amount of increase in mean CX3CL1, CCL17, CXCR4 and CXCL12 gene expression levels in the tissues of pregnant women with missed abortion was statistically higher than the pregnant women who underwent voluntary abortion, the amount of increase in ICAM5 gene expression was found to be lower (P<0.001) in those with missed abortion. In conclusion, the findings of the present study suggested that CCL17, CX3CL1, CXCL12, CXCR4 and ICAM5 may be associated with missed abortion and may play an important role in placental invasion and the continuation of pregnancy.

Introduction

Early pregnancy loss or missed abortion observed in the first trimester of pregnancy is a situation that can be noticed late since the miscarriage event does not occur, despite the embryo has lost its vitality in the uterus. Missed abortion is the most common complication of all pregnancies (1,2). Impairment of the implantation process of an active trophoblast with placental cells at 5-6 weeks of pregnancy can lead to numerous serious pregnancy complications such as abortion in the first trimester, rupture of prenatal membranes, preterm labor, fetal growth restriction and preeclampsia in the third trimester (1-4).

While chemokines are generally involved in homeostasis of the immune system, inducible chemokines may also play a role mainly in inflammatory processes. Chemokines are divided into four subfamilies based on the number and spacing of the first two cysteine residues in a conserved cysteine structure (4). These four subfamilies are named C, CC, CXC and CX3C with C being a cysteine and X an amino acid residue. Among the proteins in the CX3C subclass, CX3CL1 (also called fractalkine) is synthesized as a transmembrane molecule that can be released into the circulation as a soluble isoform by metalloprotease-dependent shedding (5,6). Among the chemokines, CX3CL1, CCL17, CXCR4, chemokine ligand 12 (CXCL12) and intercellular adhesion molecule (ICAM) 5 are proteins that can be released from tissues and mediate the migration of immune system cells to tissues (5-7). Further research is needed to show that not all other markers from the cytokine family are equally affected. The thymus and activation-regulated chemokine CCL17 is one of the inducible chemokines and is produced by endometrial gland cells during pregnancy. CXCL12 and its receptors CXCR4 are widely produced at the maternal-fetal interface and play a regulatory role in materno-fetal dialogue and immune tolerance during early pregnancy. It has been reported that CX3CL1 is increased in the first trimester of pregnancy and in term pregnancy complicated with preeclampsia (6-11).

In the present study, it was aimed to examine the levels of CX3CL1, CCL17, CXCR4, CXCL12 and ICAM5 in decidual tissue and to show their relationship with missed abortion and their utility as a marker for pregnancy outcomes.

Materials and methods

Patients

The present prospectively designed study was approved (approval no. 06) by the Local Ethics Committee of Yeni Yuzyil University (Istanbul, Turkey). Written informed consent was obtained from all patients. The study was performed with patients admitted to the Department of Obstetrics and Gynecology of İstanbul Gaziosmanpasa Hospital (Yeni Yuzyil University). A total of 15 patients aged 18-40 years, who presented with a negative fetal heartbeat between 6 and 10 gestational weeks to the obstetrics and gynecology outpatient clinics of the hospital and who had no additional systemic disease were included. The control group consisted of 13 patients between 6 and 10 gestational weeks, who presented with a positive fetal heartbeat and requested a voluntary abortion. Women <18 years of age, with multiple pregnancies, hypertension, diabetes, active maternal infection, chronic renal failure, retroplacental hematoma or systemic lupus erythematosus were excluded from the study.

Fresh materials recovered after therapeutic curettage were stored at -20˚C until the analysis. The materials were sent to Adnan Menderes University Faculty of Medicine Biochemistry Research Laboratory for the analysis of markers. CX3CL1, CCL17, CXCR4, CXCL12 and ICAM5 protein levels were determined by ELISA and gene expression levels by reverse transcription-quantitative (RT-q)PCR in fresh materials.

Gene expression of CX3CL1, CCL17, CXCR4, CXCL12, ICAM5 by RT-qPCR

A total of 5 tissue sections (each 10-µm thick) were collected from each material and put into 1.5-ml microfuge tubes. RNA isolation from tissues was performed in duplicate through the use of a commercially available FFPE RNA isolation kit (cat. no. K156002; Invitrogen; Thermo Fisher Scientific, Inc.) following the manufacturer's instructions. A total of 1 µg RNA was reverse transcribed using High Capacity cDNA Reverse Transcription kit (Applied Biosystems; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The amplification was carried out using ready-to-order primers. The following primer sequences were used for amplification: CX3CL1 forward, 5'-CTTCCCAGGAAGCACAGAGG-3' and reverse, 5'-CCTCCATCCTGAGCCTTTGG-3'; CCL17 forward, 5'-ACTTCAAGGGAGCCATTCCC-3' and reverse, 5'-CATCCCTGGAGCAGTCCTCA-3'; CXCR4 forward, 5'-TGACGGACAAGTACAGGCTGC-3' and reverse 5'-CCAGAAGGGAAGCGTGATGA-3'; CXCL12 forward, 5'-TGCCAGAGCCAACGTCAAG-3' and reverse, 5'-CAGCCGGGCTACAATCTGAA-3'; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward, 5'-AGGGCTGCTTTTAACTCTGGT-3', and reverse, 5'-CCCCACTTGATTTTGGAGGGA-3, and ICAM5 forward, 5'-AGATCGCGTAGAGCTGATGC-3' and reverse, 5'-ACCCTACAGCTCAGGGTGAA-3'.

A total of 100 ng of cDNA were amplified using SYBRGreen PCR Master Mix (Applied Biosystems; Thermo Fisher Scientific, Inc.) on the ABI StepOne Plus detection system. The thermocycling conditions for qPCR were as follows: 95˚C for 10 min, then 40 cycles of: 95˚C for 15 sec and 60˚C for 1 min. The results were analyzed using StepOne Software v2.3 (Applied Biosystems; Thermo Fisher Scientific, Inc.), using the 2-ΔΔCq method (12) and normalized to GAPDH mRNA results. Data are expressed as fold induction relative to the controls.

Protein levels of CX3CL1, CCL17, CXCR4, CXCL12 and ICAM5 by ELISA

A total of 4 tissue sections (each 10-15 µm thick) were collected from each material and put into a 1.5 ml centrifuge tube. The samples were incubated in a 250 µl buffer (pH 7.5, 0.05 M Tris, 1 mM EDTA, and 0.5% Tween-20). Tissue samples were homogenized thoroughly and kept samples on ice for 30 min. Samples were Centrifuged at 10,000 x g for 20 min at 4˚C and the supernatant was used for measurement. Protein concentrations were measured with Bradford method (13). The levels of CX3CL1, CCL17, CXCR4, CXCL12 and ICAM5 were determined with the sandwich ELISA method in accordance with the manufacturer's protocols (cat. no. EH0255; Wuhan Fine Biotech Co., Ltd.) with inter-assay cv: <12% and intra-assay cv: <10%, respectively. IFN-γ and IRF5 values were presented as ng/µg protein. All ELISA measurements were performed using a microplate reader (BioTek Epoch). Results were presented as ml/mg of protein.

Statistical analysis

The sample size of the study was calculated using G*Power software (version 3.1.9.7; http://www.gpower.hhu.de/). While calculating the sample size, the effect size was taken as 0.2, the type1 error as 0.05, and the power as 0.8. Statistical analyses were performed using SPSS 25.0 software (IBM Corp.). Descriptive data are expressed as numbers and percentages. Normality of continuous variables was verified with the Kolmogorov-Smirnov Test. Differences between groups in terms of normally-distributed continuous variables were evaluated with an independent samples t-test. The differences between the groups in terms of median values of the non-normally distributed variables were analyzed with the Mann-Whitney U test. Box-and-whisker plots were used to show to compare the medians and quartiles of CCL17, ICAM5, CX3CL1, CXCL12 and CXCR4 between the groups (Fig. 1). Receiver operating characteristic (ROC) analysis was conducted to determine a threshold value for CXCL12 for discrimination of missed and voluntary abortion. The results were evaluated within the 95% confidence interval and P<0.05 was considered to indicate a statistically significant difference.

Results

The mean age of the pregnant women was 29.7±4.7 years (Table I). There was no difference for age between groups. Patient characteristics were shown in Table I. The median CCL17 (274.9 vs. 133.8 pg/mg protein; P=0.008), CX3CL1 (765.2 vs. 284.8 pg/mg protein; P=0.001), CXCL12 (1.6 vs. 0.2 ng/mg protein; P<0.001) and CXCR4 (473.8 vs. 405.6 pg/mg protein; P=0.018) protein levels were statistically significantly higher in the pregnant women with missed abortion compared with those with voluntary abortion (Fig. 1). The median ICAM5 protein level was significantly lower in the missed abortion group than in the voluntary abortion group (1.0 vs. 1.6 ng/mg protein; P<0.001) (Table II) (Fig. 1).

Table I

Demographic characteristics of the studied population.

Table I

Demographic characteristics of the studied population.

 Missed abortion (n=15)Voluntary abortion (n=13)
CharacteristicsMedian (IQR)Mean ± SDMedian (IQR)Mean ± SDP-value
Age, years30(7)29.5±4.131(8)30.2±60.749a
Gravida2(1)1.8±0.71(2)1.8±10.65b
Parity1(1)0.6±0.61(2)0.8±0.80.683b
Weight (kg)60(10)60.8±10.963(17)64.8±9.80.325a
Height (cm)160(2)159.4±5.2161(6)162.5±40.095b
Gestational week8(1)8.1±0.76 (0)6±0.6 <0.001b
BMI (kg/m2)22.7 (3.2)23.9±3.923.4 (5.5)24.6±4.40.504b

[i] aIndependent samples t-test was used for comparison due to the normal distribution of the variables verified with the Kolmogorov-Smirnov test.

[ii] bMann-Whitney U test was used for comparison. IQR, inter-quartile range; SD, standard deviation; BMI, body mass index.

Table II

Comparison of mean gene and protein expression levels of chemokines in decidual tissues of patients between groups.

Table II

Comparison of mean gene and protein expression levels of chemokines in decidual tissues of patients between groups.

 Missed abortion (n=15)Voluntary abortion (n=13)
CharacteristicsMedian (IQR)Mean ± SDMedian (IQR)Mean ± SDP-value
CCL17 (pg/mg protein)274.9(239)264.9±130.3133.8(75)140.3±45.70.008a
ICAM5 (ng/mg protein)1.0 (0)1.03±0.31.6(1)1.6±0.4 <0.001b
CX3CL1 (pg/mg protein)765.2(726)874.1±521.7284.8(199)349.1±202.20.001a
CXCL12 (ng/mg protein)1.6 [1]1.57±0.680.2 (0)0.3±0.1 <0.001a
CXCR4 (pg/mg protein)473.8(93)469.7±89.5405.6(42)408.6±68.80.018a
CCL17/GAPDH2.9 (0)2.9±0.31.2 (0)1.2±0.2 <0.001a
ICAM5/GAPDH0.8 (0)0.9±0.21.3 (0)1.3±0.23 <0.001b
CX3CL1/GAPDH2.9(1)3.0±0.81.1 (0)1.2±0.2 <0.001a
CXCL12/GAPDH2.7(2)2.8±11.1 (0)1.1±0.2 <0.001a
CXCR4/GAPDH1.2 (0)1.3±0.41.0 (0)0.9±0.30.013b

[i] aMann-Whitney U test was used for comparison.

[ii] bIndependent samples t-test was used for comparison due to the normal distribution of the variables verified with the Kolmogorov-Smirnov test. IQR, inter-quartile range; SD, standard deviation; GADPH, glyceraldehyde-3-phosphate dehydrogenase; CXCL12, chemokine ligand 12; ICAM5, intercellular adhesion molecule 5.

The median amount of increase in gene expression levels of CCL17/GAPDH (2.9 vs. 1.2 fold increase; P<0.001), CX3CL1/GAPDH (2.9 vs. 1.1 fold increase; P<0.001), CXCL12/GAPDH (2.7 vs. 1.1 fold increase; P<0.001) and the mean CXCR4/GAPDH (1.3 vs. 0.9 fold increase; P=0.013) was found to be significantly higher in tissues of pregnant women with missed abortion than that of the pregnant women with voluntary abortion. The mean amount of increase in ICAM5/GAPDH tissue gene expression level was significantly lower in the missed abortion group than in the voluntary abortion group (0.9 vs. 1.3 fold increase; P<0.001) (Table II) (Fig. 2). ROC analysis revealed that a threshold value of 0.66 ng/mg protein for CXCL12 had a sensitivity and specificity of 100% for determination of missed abortion (AUC: 1; lower bound: 1.0; upper bound: 1.0; P<0.001) (Fig. 3).

Discussion

In the present study, it was found that median CCL17, CX3CL1, CXCL12 and CXCR4 protein levels were significantly higher in pregnant women with missed abortion than in those with voluntary abortion. The mean ICAM5 protein level was identified to be significantly lower in the missed abortion group compared with the voluntary abortion group. When chemokines were examined in terms of gene expression levels, the median amounts of increase in gene expression levels of CCL17, CX3CL, CXCL12 and CXCR4 were significantly higher in the missed abortion group compared with the voluntary abortion group. The mean amount of increase in gene expression levels of ICAM5 protein was significantly lower in the missed abortion group compared with the voluntary abortion group. The maternal component of the placenta was used as the material. The maternal component of the placenta is known as the decidua basalis. Oxygen and nutrients from maternal blood diffuse through the villus walls in the intervillous spaces and enter the fetal capillaries. Also decidua secretes hormones, growth factors and cytokines. It has receptors for estrogen, progesterone, growth hormone, and others. If missed abortion is not diagnosed, it may be accompanied by maternal complications such as septic abortion or excessive bleeding (4). In addition, the obtained data will shed light on recurrent spontaneous pregnancy losses. Certain studies have shown that these 5 chemokines (CX3CL1, CCL17, CXCR4, CXCL12 and ICAM5) that were studied play a role in the implantation process of the embryo (9,8,14-16).

CX3CL1 has recently attracted attention in the field of reproductive research by regulating adhesion and migration processes in fetal-maternal interaction at different stages of human pregnancy (8). In addition, an increasing body of evidence has suggested that a number of pregnancy pathologies are associated with increased placental CX3CL1 expression, including chorioamnionitis (17), diabetic pregnancy (18), and severe early-onset preeclampsia (19,20). In a previous study by Hannan et al (21) investigating the CX3CL1 level in the serum of 34 first trimester abortions and 44 normal births, CXCL3 was not detected in term patients, but it was found in the aborted group. Li et al (22) detected significantly upregulated expression of CX3CL1 and CX3CL1 receptor in the uterus of IFN-γ-induced aborted mice. In the present study, the median CX3CL1 protein and gene expression levels were found to be significantly higher in pregnant women with missed abortion compared with pregnant women with voluntary abortion. The abortion week in the materials received was at most 10 weeks, and it was observed in only 1 patient. Brain tissue is not considered to be dominant for such a small fetus. Similarly, the brain tissue is damaged in voluntary abortion cases. The present data are consistent with previous studies showing the role of CX3CL1 in the feto-maternal interaction in the process of placental invasion and indicated that CX3CL1 may be associated with missed abortion (20,21).

Chemokines are unique proteins with the ability to control immune cell chemoattraction and participate in cell proliferation, migration and apoptosis. CXCL12 can modulate the proliferation, invasion and survival of human trophoblasts that are crucial for establishing a successful pregnancy (23-25). CXCL12 and its receptor CXCR4 are involved in uterine natural killer cell recruitment, placentation, vascular remodeling, embryogenesis, and cardiovascular and central nervous system organogenesis (23-29). Suppression of CXCL12/CXCR4 signaling during the small window of conceptus implantation reduces placental vascularization, induces autophagy, and moistens the inflammatory placental environment (30-33). In addition, recent evidence has suggested that suppression of CXCL12-induced actions at the fetal-maternal interface reduces trophoblast invasion into the maternal endometrium and delays uterine remodeling (30). Chao et al (34) found that the expression of CXCL12 chemokine and its receptor CXCR4 increased in the abortion material induced in mice with IFN-gamma. In another study, Dimova et al revealed an increased expression of CXCL12 chemokine and its receptor CXCR4 in the decidua of 30 patients with spontaneous abortion compared with 15 patients with elective abortion (35). In the present study, the median protein level and gene expression of CXCL12 and CXCR4 were found to be significantly higher in pregnant women with missed abortion than in pregnant women with voluntary abortion. In addition, the present findings revealed a highly reliable threshold value for CXCL12 (with a sensitivity and specificity of 100%) in discrimination of missed and voluntary abortions. These findings showed the association of these molecules with missed abortion.

It has been reported that CCL17 level does not change in cases of spontaneous abortion (11). In the present study, the mean protein level and gene expression of CCL17 were identified to be significantly higher in pregnant women with missed abortion than in pregnant women with voluntary abortion. Furthermore, the mean ICAM5 protein level was found to be significantly lower in pregnant women with missed abortion than in the those with voluntary abortion. As ICAM5 is solely formed in the brain tissue, its level may be reduced in abortion cases due to lack of brain development (36). However, it was planned to discriminate the abortion whether it was missed or voluntary, thus the voluntary abortion cases were used as the control group. According to the present findings, it was observed that brain tissue is damaged in missed abortion significantly more than the voluntary abortion cases.

Since the present study was planned as a cohort study, the pregnant women were not followed up for a long time after abortion and the long-term changes in the levels of these molecules were not examined, which can be considered as the major limitation of the present study. Again, there is a need for further studies on whether the amount of gene expression in the tissue changes on the day of missed abortion diagnosis. Another limitation is the relatively small number of pregnant women included in the study, although it was sufficient for statistical analysis. In addition, other markers from the family of cytokines also need to be investigated to reveal that not all are equally affected. In future studies, broader genetic analyzes can be obtained by examining the relationship between karyotype analyses and chemokines in missed abortion.

In conclusion, the findings of the present study suggested that CCL17, CX3CL1, CXCL12, CXCR4 and ICAM5 may be associated with missed abortion and may play an important role in placental invasion and the continuation of pregnancy. However, further comprehensive studies are needed to draw more definitive conclusions.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

DH was involved in project development and manuscript writing. SG was responsible for data collection, management and analysis. OC and DH confirm the authenticity of all the raw data. OC and VT contributed to data analysis, manuscript writing and editing. All authors have read and approved the manuscript.

Ethics approval and consent to participate

The present prospectively designed study was approved (approval no. 06) by the local ethics committee of Yeni Yuzyil University (Istanbul, Turkey). Written informed consent was obtained from all patients.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Hanschmidt F, Linde K, Hilbert A, Riedel-Heller SG and Kersting A: Abortion stigma: A systematic review. Perspect Sex Reprod Health. 48:169–177. 2016.PubMed/NCBI View Article : Google Scholar

2 

Kapp N and Lohr PA: Modern methods to induce abortion: Safety, efficacy and choice. Best Pract Res Clin Obstet Gynaecol. 63:37–44. 2020.PubMed/NCBI View Article : Google Scholar

3 

Conti J and Cahill EP: Self-managed abortion. Curr Opin Obstet Gynecol. 31:435–440. 2019.PubMed/NCBI View Article : Google Scholar

4 

Griebel CP, Halvorsen J, Golemon TB and Day AA: Management of spontaneous abortion. Am Fam Physician. 72:1243–1250. 2005.PubMed/NCBI

5 

Hughes CE and Nibbs RJB: A guide to chemokines and their receptors. FEBS J. 285:2944–2971. 2018.PubMed/NCBI View Article : Google Scholar

6 

Palomino DC and Marti LC: Chemokines and immunity. Einstein (Sao Paulo). 13:469–473. 2015.PubMed/NCBI View Article : Google Scholar : (İn English, Portuguese).

7 

Legler DF and Thelen M: Chemokines: Chemistry, biochemistry and biological function. Chimia (Aarau). 70:856–859. 2016.PubMed/NCBI View Article : Google Scholar

8 

Kervancioglu Demirci E, Salamonsen LA and Gauster M: The role of CX3CL1 in fetal-maternal interaction during human gestation. Cell Adh Migr. 10:189–196. 2016.PubMed/NCBI View Article : Google Scholar

9 

Ao D, Li DJ and Li MQ: CXCL12 in normal and pathological pregnancies: A review. Am J Reprod Immunol. 84(e13280)2020.PubMed/NCBI View Article : Google Scholar

10 

Gahmberg CG, Ning L and Paetau S: ICAM-5: A neuronal dendritic adhesion molecule involved in immune and neuronal functions. Adv Neurobiol. 8:117–132. 2014.PubMed/NCBI View Article : Google Scholar

11 

Rasmark ER, Bruno V, Nedstrand E, Boij R, Strid CP, Piccione E, Berg G, Svensson-Arvelund J, Jenmalm MC, Rubér M and Ernerudh J: Low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: A randomised controlled trial. Sci Rep. 9(12314)2019.PubMed/NCBI View Article : Google Scholar

12 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

13 

Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976.PubMed/NCBI View Article : Google Scholar

14 

Zlotnik A and Yoshie O: Chemokines: A new classification system and their role in immunity. Immunity. 12:121–127. 2000.PubMed/NCBI View Article : Google Scholar

15 

Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ and Raines EW: Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 276:37993–38001. 2001.PubMed/NCBI View Article : Google Scholar

16 

Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al: The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 102:1186–1195. 2003.PubMed/NCBI View Article : Google Scholar

17 

Szukiewicz D, Kochanowski J, Mittal TK, Pyzlak M, Szewczyk G and Cendrowski K: Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by human amniotic epithelial cells (HAEC) under normoxic and hypoxic conditions. J Inflamm (Lond). 11(12)2014.PubMed/NCBI View Article : Google Scholar

18 

Szukiewicz D, Kochanowski J, Pyzlak M, Szewczyk G, Stangret A and Mittal TK: Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta. Mediators Inflamm. 2013(437576)2013.PubMed/NCBI View Article : Google Scholar

19 

Siwetz M, Dieber-Rotheneder M, Cervar-Zivkovic M, Kummer D, Kremshofer J, Weiss G, Herse F, Huppertz B and Gauster M: Placental fractalkine is up-regulated in severe early-onset preeclampsia. Am J Pathol. 185:1334–1343. 2015.PubMed/NCBI View Article : Google Scholar

20 

Usta A, Turan G, Sancakli Usta C, Avci E and Adali E: Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 33:806–815. 2020.PubMed/NCBI View Article : Google Scholar

21 

Hannan NJ, Bambang K, Kaitu'u-Lino TJ, Konje JC and Tong S: A bioplex analysis of cytokines and chemokines in first trimester maternal plasma to screen for predictors of miscarriage. PLoS One. 9(e93320)2014.PubMed/NCBI View Article : Google Scholar

22 

Li ZY, Chao HH, Liu HY, Song ZH, Li LL, Zhang YJ, Yang Y and Peng JP: IFN-γ induces aberrant CD49b+ NK cell recruitment through regulating CX3CL1: A novel mechanism by which IFN-γ provokes pregnancy failure. Cell Death Dis. 5(e1512)2014.PubMed/NCBI View Article : Google Scholar

23 

Kumar A, Kumar S, Dinda AK and Luthra K: Differential expression of CXCR4 receptor in early and term human placenta. Placenta. 25:347–351. 2004.PubMed/NCBI View Article : Google Scholar

24 

Schanz A, Red-Horse K, Hess AP, Baston-Büst DM, Heiss C and Krüssel JS: Oxygen regulates human cytotrophoblast migration by controlling chemokine and receptor expression. Placenta. 35:1089–1094. 2014.PubMed/NCBI View Article : Google Scholar

25 

Jaleel MA, Tsai AC, Sarkar S, Freedman PV and Rubin LP: Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod. 10:901–909. 2004.PubMed/NCBI View Article : Google Scholar

26 

Wu X, Jin LP, Yuan MM, Zhu Y, Wang MY and Li DJ: Human first-trimester trophoblast cells recruit CD56brightCD16-NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. J Immunol. 175:61–68. 2005.PubMed/NCBI View Article : Google Scholar

27 

Barrientos G, Tirado-González I, Freitag N, Kobelt P, Moschansky P, Klapp BF, Thijssen VL and Blois SM: CXCR4(+) dendritic cells promote angiogenesis during embryo implantation in mice. Angiogenesis. 16:417–427. 2013.PubMed/NCBI View Article : Google Scholar

28 

Virgintino D, Errede M, Rizzi M, Girolamo F, Strippoli M, Wälchli T, Robertson D, Frei K and Roncali L: The CXCL12/CXCR4/CXCR7 ligand-receptor system regulates neuro-glio-vascular interactions and vessel growth during human brain development. J Inherit Metab Dis. 36:455–466. 2013.PubMed/NCBI View Article : Google Scholar

29 

Zhu Y and Murakami F: Chemokine CXCL12 and its receptors in the developing central nervous system: Emerging themes and future perspectives. Dev Neurobiol. 72:1349–1362. 2012.PubMed/NCBI View Article : Google Scholar

30 

McIntosh SZ, Maestas MM, Dobson JR, Quinn KE, Runyan CL and Ashley RL: CXCR4 signaling at the fetal-maternal interface may drive inflammation and syncytia formation during ovine pregnancy†. Biol Reprod. 104:468–478. 2021.PubMed/NCBI View Article : Google Scholar

31 

McIntosh SZ, Maxam CJ, Maestas MM, Quinn KE and Ashley RL: Intrauterine inhibition of chemokine receptor 4 signaling modulates local and systemic inflammation in ovine pregnancy. Am J Reprod Immunol. 82(e13181)2019.PubMed/NCBI View Article : Google Scholar

32 

Quinn KE, Prosser SZ, Kane KK and Ashley RL: Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: Alterations in expression of chemokines, angiogenic factors and their receptors. J Anim Sci. 95:1144–11153. 2017.PubMed/NCBI View Article : Google Scholar

33 

Runyan CL, McIntosh SZ, Maestas MM, Quinn KE, Boren BP and Ashley RL: CXCR4 signaling at the ovine fetal-maternal interface regulates vascularization, CD34+ cell presence, and autophagy in the endometrium†. Biol Reprod. 101:102–111. 2019.PubMed/NCBI View Article : Google Scholar

34 

Chao HH, Li L, Gao X, Wang C and Yue W: CXCL12 expression in aborted mouse uteri induced by IFN-γ: Potential anti-inflammatory effect involves in endometrial restoration after abortion in mice. Gene. 700:38–46. 2019.PubMed/NCBI View Article : Google Scholar

35 

Dimova I, Rizov M, Giragosyan S, Koprinarova M, Tzoneva D, Belemezova K, Hristova-Savova M, Milachich T, Djonov V and Shterev A: Molecular pathogenesis of spontaneous abortions-Whole genome copy number analysis and expression of angiogenic factors. Taiwan J Obstet Gynecol. 59:99–104. 2020.PubMed/NCBI View Article : Google Scholar

36 

Gahmberg CG, Tian L, Ning L and Nyman-Huttunen H: ICAM-5-a novel two-facetted adhesion molecule in the mammalian brain. Immunol Lett. 117:131–135. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

June-2022
Volume 23 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gokce S, Herki̇loglu D, Cevi̇k O and Turan V: Role of chemokines in early pregnancy loss. Exp Ther Med 23: 397, 2022
APA
Gokce, S., Herki̇loglu, D., Cevi̇k, O., & Turan, V. (2022). Role of chemokines in early pregnancy loss. Experimental and Therapeutic Medicine, 23, 397. https://doi.org/10.3892/etm.2022.11324
MLA
Gokce, S., Herki̇loglu, D., Cevi̇k, O., Turan, V."Role of chemokines in early pregnancy loss". Experimental and Therapeutic Medicine 23.6 (2022): 397.
Chicago
Gokce, S., Herki̇loglu, D., Cevi̇k, O., Turan, V."Role of chemokines in early pregnancy loss". Experimental and Therapeutic Medicine 23, no. 6 (2022): 397. https://doi.org/10.3892/etm.2022.11324